Novo Nordisk Retained Earnings (Accumulated Deficit) 2010-2024 | NVO
Novo Nordisk retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $16.183B, a 25.7% increase year-over-year.
- Novo Nordisk retained earnings (accumulated deficit) for 2023 were $15.223B, a 33.4% increase from 2022.
- Novo Nordisk retained earnings (accumulated deficit) for 2022 were $11.411B, a 0.39% decline from 2021.
- Novo Nordisk retained earnings (accumulated deficit) for 2021 were $11.456B, a 17.25% increase from 2020.